hotspot -WSS

hotspot

author：focus 2025-09-27 10:05:56 - browse：58

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medicare details structure of new drug price negotiation program
Next article： House panel to mark up pandemic

knowledge

WSS

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

7 people shot in DC, police say

Another man arrested in connection with shooting at Kansas nightclub

Meta looks to target Twitter with a rival app called Threads

New case study details death in closely watched Alzhiemer's trial

North Korean leader's powerful sister says warplanes repelled US spy plane

knowledge

hotspot

entertainment

Moonlake's readout produced a cash windfall. Risks remain

Drinking water from half of US faucets contains PFAS: Study

Alkermes shareholders re

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Doctor appointment wait times are getting worse

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

A new study asks: Are we harming blood donors by taking blood?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Neutralizing antibodies against HIV shows promise in children

focus

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

Grail is spending more than ever lobbying Congress

Why is France rioting? What to know about the fatal police shooting of Nahel M

Meta looks to target Twitter with a rival app called Threads

entertainment

knowledge

knowledge

focus